litlas
Log inCreate account

Manisha H. Shah

Active 1999–2024

84
Papers
31,611
Citations
63
h-index
81
i10-index

Citations

Citations per year for Manisha H. Shah1992: 1 citations1996: 1 citations1999: 2 citations2000: 13 citations2001: 23 citations2002: 18 citations2003: 13 citations2004: 17 citations2005: 16 citations2006: 35 citations2007: 70 citations2008: 93 citations2009: 169 citations2010: 153 citations2011: 216 citations2012: 218 citations2013: 193 citations2014: 240 citations2015: 185 citations2016: 213 citations2017: 225 citations2018: 195 citations2019: 736 citations2020: 1,113 citations2021: 1,408 citations2022: 1,290 citations2023: 898 citations2024: 1,325 citations2025: 591 citations2026: 8 citations1993–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,344 citing papers, 26.5% of this breakdownChina: 1,301 citing papers, 10.3% of this breakdownItaly: 997 citing papers, 7.9% of this breakdownUnited Kingdom: 650 citing papers, 5.2% of this breakdownGermany: 640 citing papers, 5.1% of this breakdownFrance: 611 citing papers, 4.8% of this breakdownJapan: 570 citing papers, 4.5% of this breakdownSpain: 431 citing papers, 3.4% of this breakdownCanada: 376 citing papers, 3% of this breakdownNetherlands: 348 citing papers, 2.8% of this breakdownSouth Korea: 307 citing papers, 2.4% of this breakdownAustralia: 302 citing papers, 2.4% of this breakdown
0%26.5%Other 21.7%

Institutions

Fields

  • Medicine76%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Immunology and Microbiology4.2%
  • Neuroscience1.3%
  • Computer Science0.3%
  • Engineering0.3%
  • Other1.1%

Topics

  • Thyroid Cancer Diagnosis and Treatment5.9%
  • Cancer Immunotherapy and Biomarkers5.6%
  • Neuroendocrine Tumor Research Advances5.2%
  • Lung Cancer Research Studies4.1%
  • Cancer Genomics and Diagnostics3%
  • Pancreatic and Hepatic Oncology Research2.9%
  • Other73.3%

Coauthors

All papers

Open in search
  1. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

    Authors: Aurélien Marabelle, Marwan Fakih, Juanita Lopez, Manisha H. Shah, Ronnie Shapira‐Frommer, Kazuhiko Nakagawa, Hyun Cheol Chung, Hedy L. Kindler, José A. López-Martín, Wilson H. Miller, Antoîne Italiano, Steven Kao, Sarina A. Piha‐Paul, Jean‐Pierre Delord, Robert R. McWilliams, David Fabrizio, Deepti Aurora-Garg, Lei Xu, Fan Jin, Kevin Norwood, Yung‐Jue Bang - The Lancet Oncology 2020 cited by 2,492

  2. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

    Authors: Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto, Anna Maria Di Giacomo, Ana De Jesus‐Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R. Hansen, Sarina A. Piha‐Paul, Toshihiko Doi, Bo Gao, Hyun Cheol Chung, José A. López-Martín, Yung-Jue Bang, Ronnie Shapira Frommer, Manisha H. Shah, Razi Ghori, Andrew K. Joe, Scott K. Pruitt, Luis A. Díaz - Journal of Clinical Oncology 2019 cited by 2,963

  3. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

    Authors: Samuel A. Wells, L. Sylvia, Henning Dralle, Rossella Elisei, Douglas B. Evans, Robert F. Gagel, Nancy Y. Lee, Andreas Machens, Jeffrey F. Moley, Furio Pacini, Friedhelm Raue, Karin Frank‐Raue, Bruce Robinson, M. Sara Rosenthal, Massimo Santoro, Martin Schlumberger, Manisha H. Shah, Steven G. Waguespack - Thyroid 2015 cited by 2,400

  4. Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

    Authors: Martin Schlumberger, Makoto Tahara, Lori J. Wirth, Bruce Robinson, Marcia S. Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H. Shah, Ana O. Hoff, Andrew G. Gianoukakis, Naomi Kiyota, Matthew H. Taylor, Sung‐Bae Kim, Monika K. Krzyzanowska, Corina E. Dutcus, Begoña de las Heras, Junming Zhu, Steven I. Sherman - New England Journal of Medicine 2015 cited by 2,071

  5. Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer

    Authors: Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Herbert H. Loong, Melissa L. Johnson, Justin F. Gainor, Caroline E. McCoach, Oliver Gautschi, Benjamin Besse, Byoung Chul Cho, Nir Peled, Jared Weiss, Yu-Jung Kim, Yuichiro Ohe, Makoto Nishio, Keunchil Park, Jyoti D. Patel, Takashi Seto, Tomohiro Sakamoto, Ezra Y. Rosen, Manisha H. Shah, Fabrice Barlési, Philippe A. Cassier, Lyudmila Bazhenova, Filippo de Braud, Elena Garralda, Vamsidhar Velcheti, Miyako Satouchi, Kadoaki Ohashi, Nathan A. Pennell, Karen L. Reckamp, Grace K. Dy, Jürgen Wolf, Benjamin Solomon, Gerald S. Falchook, Kevin Ebata, Michele Nguyen, Binoj C. Nair, Edward Y. Zhu, Luxi Yang, Xin Huang, Elizabeth Olek, S. Michael Rothenberg, Kōichi Goto, Vivek Subbiah - New England Journal of Medicine 2020 cited by 836

  6. Efficacy of Selpercatinib in RET -Altered Thyroid Cancers

    Authors: Lori J. Wirth, Eric J. Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen H. Lorch, Francis P. Worden, Marcia S. Brose, Jyoti D. Patel, Sophie Leboulleux, Yann Godbert, Fabrice Barlési, John C. Morris, Taofeek K. Owonikoko, Daniel S.W. Tan, Oliver Gautschi, Jared Weiss, Christelle de la Fouchardière, Mark E. Burkard, Janessa Laskin, Matthew H. Taylor, Matthias Kroiß, Jacques Médioni, Jonathan W. Goldman, Todd M. Bauer, Benjamin Levy, Viola W. Zhu, Nehal J. Lakhani, Víctor Moreno, Kevin Ebata, Michele Nguyen, Dana Heirich, Edward Y. Zhu, Xin Huang, Luxi Yang, Jennifer Kherani, S. Michael Rothenberg, Alexander Drilon, Vivek Subbiah, Manisha H. Shah, Maria E. Cabanillas - New England Journal of Medicine 2020 cited by 773

  7. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

    Authors: Keith C. Bible, Electron Kebebew, James D. Brierley, Juan P. Brito, Maria E. Cabanillas, Thomas J. Clark, Antonio Di Cristofano, Robert L. Foote, Thomas J. Giordano, Jan L. Kasperbauer, Kate Newbold, Yuri E. Nikiforov, Gregory W. Randolph, M. Sara Rosenthal, Anna M. Sawka, Manisha H. Shah, Ashok R. Shaha, Robert C. Smallridge, Carol K. Wong-Clark - Thyroid 2021 cited by 709

  8. Everolimus for Advanced Pancreatic Neuroendocrine Tumors

    Authors: James C. Yao, Manisha H. Shah, Tetsuhide Ito, C. Lombard Bohas, Edward M. Wolin, Eric Van Cutsem, Timothy J. Hobday, Takuji Okusaka, Jaume Capdevila, Elisabeth G.E. de Vries, Paola Tomassetti, Marianne Pavel, Sakina Hoosen, T Haas, Jeremie Lincy, David Lebwohl, Kjell Öberg - New England Journal of Medicine 2011 cited by 2,848

  9. American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

    Authors: Robert C. Smallridge, Kenneth B. Ain, L. Sylvia, Keith C. Bible, James D. Brierley, Kenneth D. Burman, Electron Kebebew, Nancy Y. Lee, Yuri E. Nikiforov, M. Sara Rosenthal, Manisha H. Shah, Ashok R. Shaha, R. Michael Tuttle for the American Thyroid Ass - Thyroid 2012 cited by 935

  10. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: Manisha H. Shah, Whitney Goldner, Al B. Benson, Emily K. Bergsland, Lawrence S. Blaszkowsky, Pamela Brock, J.K.C. Chan, Satya Das, Paxton V. Dickson, Paul T. Fanta, Thomas J. Giordano, Þorvarður R. Hálfdánarson, Daniel M. Halperin, Jin He, Anthony P. Heaney, Martin J. Heslin, Fouad Kandeel, Arash Kardan, Sajid Khan, Boris W. Kuvshinoff, Christopher H. Lieu, Kimberly D. Miller, Venu G. Pillarisetty, Diane Reidy‐Lagunes, Sarimar Agosto Salgado, Shagufta Shaheen, Heloisa P. Soares, Michael C. Soulen, Jonathan Strosberg, Craig Sussman, Nikolaos A. Trikalinos, N. Uboha, Namrata Vijayvergia, Terence Z. Wong, Beth Lynn, Cindy Hochstetler - Journal of the National Comprehensive Cancer Network 2021 cited by 602

  11. Cabozantinib in Progressive Medullary Thyroid Cancer

    Authors: Rossella Elisei, Martin Schlumberger, Stefan Müller, Patrick Schöffski, Marcia S. Brose, Manisha H. Shah, Lisa Licitra, Barbara Jarząb, В. С. Медведев, Michael C. Kreißl, Bruno Niederle, Ezra E.W. Cohen, Lori J. Wirth, Haythem Ali, Colin Hessel, Yifah Yaron, Douglas W. Ball, Barry D. Nelkin, Steven I. Sherman - Journal of Clinical Oncology 2013 cited by 1,215

  12. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

    Authors: George D. Demetri, Allan T. van Oosterom, Christopher R. Garrett, Martin E. Blackstein, Manisha H. Shah, Jaap Verweij, Grant A. McArthur, Ian Judson, Michael C. Heinrich, Jeffrey A. Morgan, Jayesh Desai, Christopher D.�M. Fletcher, Suzanne George, Carlo L. Bello, Xin Huang, Charles M. Baum, Paolo G. Casali - The Lancet 2006 cited by 2,595

  13. Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

    Authors: Pamela L. Kunz, Noah Graham, Paul J. Catalano, Halla Nimeiri, George A. Fisher, Teri A. Longacre, Carlos J. Suarez, Brock A. Martin, James C. Yao, Matthew H. Kulke, Andrew Hendifar, James C. Shanks, Manisha H. Shah, Mark M. Zalupski, Edmond L. Schmulbach, Diane Reidy‐Lagunes, Jonathan Strosberg, Peter J. O’Dwyer, Al B. Benson - Journal of Clinical Oncology 2022 cited by 294

  14. Matrix metalloproteinase 13–deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development

    Authors: Christopher B. Little, Amlan Barai, Dan Burkhardt, Susan M. Smith, Amanda Fosang, Zena Werb, Manisha H. Shah, Erik W. Thompson - Arthritis & Rheumatism 2009 cited by 629

  15. A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

    Authors: Sandip Pravin Patel, Megan Othus, Young Kwang Chae, Francis J. Giles, Donna E. Hansel, Preet Paul Singh, Annette Campbell Fontaine, Manisha H. Shah, Anup Kasi, Tareq Al Baghdadi, Marc Matrana, Zoran Gatalica, W. Michael Korn, Jourdain Hayward, Christine M. McLeod, Helen X. Chen, Elad Sharon, Edward Mayerson, Christopher W. Ryan, Melissa Plets, Charles D. Blanke, Razelle Kurzrock - Clinical Cancer Research 2020 cited by 326

  16. Dabrafenib Versus Dabrafenib + Trametinib in BRAF -Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial

    Authors: Naifa L. Busaidy, Bhavana Konda, Lai Wei, Lori J. Wirth, Catherine Devine, Gregory A. Daniels, Jonas DeSouza, Ming Poi, Nathan D. Seligson, Maria E. Cabanillas, Jennifer A. Sipos, Matthew D. Ringel, Ann‐Kathrin Eisfeld, Cynthia Timmers, Manisha H. Shah - Thyroid 2022 cited by 106

  17. Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study

    Authors: Jonathan Strosberg, Nobumasa Mizuno, Toshihiko Doi, Enrique Grande, Jean‐Pierre Delord, Ronnie Shapira‐Frommer, Emily K. Bergsland, Manisha H. Shah, Marwan Fakih, Shunji Takahashi, Sarina A. Piha‐Paul, Bert H. O’Neil, Sajeve Thomas, Martijn P. Lolkema, Menghui Chen, Nageatte Ibrahim, Kevin Norwood, Julien Hadoux - Clinical Cancer Research 2020 cited by 221

  18. Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

    Authors: Martin Schlumberger, Rossella Elisei, Stefan Müller, Patrick Schöffski, Marcia S. Brose, Manisha H. Shah, Lisa Licitra, Jolanta Krajewska, Michael C. Kreißl, Bruno Niederle, Ezra E.W. Cohen, Lori J. Wirth, Haythem Ali, D O Clary, Yifah Yaron, Milan Mangeshkar, Douglas W. Ball, Barry D. Nelkin, Steven I. Sherman - Annals of Oncology 2017 cited by 239

  19. Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study

    Authors: Do‐Youn Oh, Alain P. Algazi, Jaume Capdevila, Federico Longo, Wilson H. Miller, Jerry Tan Chun Bing, Carlos Bonilla, Hyun Cheol Chung, Tormod Kyrre Guren, Chia‐Chi Lin, Daniel Motola‐Kuba, Manisha H. Shah, Julien Hadoux, Lili Yao, Fan Jin, Kevin Norwood, Loïc Lebellec - Cancer 2023 cited by 56

  20. A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer

    Authors: Martin Schlumberger, Barbara Jarząb, Maria E. Cabanillas, Bruce Robinson, Furio Pacini, Douglas W. Ball, Judith C. McCaffrey, Kate Newbold, Roger Allison, Renato Martins, Lisa Licitra, Manisha H. Shah, Donald Bodenner, Rossella Elisei, Lynn A. Burmeister, Yasuhiro Funahashi, Min Ren, James P. O'Brien, Steven I. Sherman - Clinical Cancer Research 2015 cited by 247

  21. Oxidative Stress and the Role of NADPH Oxidase in Glaucoma

    Authors: Jennifer C. Fan Gaskin, Manisha H. Shah, Elsa C. Chan - Antioxidants 2021 cited by 64

  22. Differential Cytokine and Chemokine Gene Expression by Human NK Cells Following Activation with IL-18 or IL-15 in Combination with IL-12: Implications for the Innate Immune Response

    Authors: Todd A. Fehniger, Manisha H. Shah, Matthew J. Turner, Jeffrey VanDeusen, Susan P. Whitman, Megan A. Cooper, Kazuhiro Suzuki, Mark A. Wechser, Frederico Goodsaid, Michael A. Caligiuri - The Journal of Immunology 1999 cited by 640

  23. Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial

    Authors: Eric J. Sherman, Jonathan Harris, Keith C. Bible, Ping Xia, Ronald Ghossein, Christine H. Chung, Nadeem Riaz, G. Brandon Gunn, Robert L. Foote, Sue S. Yom, Stuart J. Wong, Shlomo A. Koyfman, Michael Dzeda, David A. Clump, Saad A. Khan, Manisha H. Shah, Kevin P. Redmond, Pedro A. Torres‐Saavedra, Quynh‐Thu Le, Nancy Y. Lee - The Lancet Oncology 2023 cited by 39

  24. Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial

    Authors: Benedito A. Carneiro, Bhavana Konda, Rubens B. Costa, Ricardo Costa, Vinay Sagar, Demirkan Gursel, Lawrence S. Kirschner, Young Kwang Chae, Sarki A. Abdulkadir, Alfred Rademaker, Devalingam Mahalingam, Manisha H. Shah, Francis J. Giles - The Journal of Clinical Endocrinology & Metabolism 2019 cited by 117